United-Guardian declares $0.25 per share dividend, plans growth initiatives

HAUPPAUGE, N.Y. - United-Guardian, Inc. (NASDAQ:UG) announced Tuesday that its Board of Directors has declared a cash dividend of $0.25 per share, payable on August 1, 2025, to stockholders of record as of July 25, 2025. The company, currently trading at $8.11, near its 52-week low of $7.73, appears undervalued according to InvestingPro analysis.

This marks the 30th consecutive year that the specialty chemicals manufacturer has distributed dividends to its shareholders, currently offering an attractive 8.63% dividend yield while trading at a modest P/E ratio of 12.88.

According to the company’s statement, the board balanced shareholder returns with funding needs for upcoming growth initiatives planned for the second half of 2025. InvestingPro analysis reveals the company maintains strong financial health with a "GOOD" overall score, supported by robust profitability metrics. Discover 6 additional exclusive ProTips about United-Guardian with an InvestingPro subscription.

"The Board believes that retaining a portion of our earnings to implement these new growth initiatives will generate greater revenues and provide stronger dividends for our stockholders in the future," said Donna Vigilante, President of United-Guardian, in the press release.

The company indicated these initiatives include new strategies to expand the market for its personal care products and a major project aimed at increasing sales of Renacidín Irrigation Solution, which the company describes as its most important pharmaceutical product.

United-Guardian manufactures cosmetic ingredients, medical lubricants, sexual wellness ingredients, and pharmaceuticals. The company’s announcement was made following the board’s meeting on July 11, 2025.

In other recent news, United-Guardian, Inc. has made significant announcements affecting its leadership and governance. The company appointed its President, Donna Vigilante, to the Board of Directors, a move aimed at enhancing global marketing strategies and boosting sales of its medical and pharmaceutical product lines. Vigilante’s extensive experience, including her role in expanding the company’s natural cosmetic ingredients line, positions her as a valuable addition to the board.

Furthermore, United-Guardian held its annual stockholders meeting, where six directors were elected to the board, indicating strong shareholder support for the current leadership. In addition to board elections, shareholders approved holding annual votes on executive compensation, reflecting a commitment to transparency and accountability. The appointment of Grassi & Co., CPAs P.C. as the independent registered public accounting firm was ratified, underscoring confidence in the company’s financial practices.

These developments come as United-Guardian continues to navigate the competitive landscape of the healthcare and cosmetics industries, with leadership expressing optimism about future initiatives.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.